Elsevier's Clinician of the Future 2025 survey: Clinicians’ AI usage and optimism grows despite concerns around trust and reliability

Clinicians across the world believe artificial intelligence (AI) can play an important role in addressing major healthcare challenges and easing burdens for doctors and nurses according to Elsevier’s Clinician of the Future 2025 annual insights report. With the healthcare landscape evolving rapidly and clinicians facing persistent challenges in delivering quality care, this new report shows how clinicians believe these challenges can be met in the years ahead.

Physicians and nurses are optimistic about the potential of AI to improve patient care in the next two to three years. Based on 2,206 survey responses from 109 countries, clinicians are most optimistic about the potential of clinical AI tools to save them time (70%), enhance diagnostic speed (58%) and accuracy (54%), and help improve patient outcomes (55%).

Their optimism is tempered by caution around trustworthiness and compliance with regulations, and a concern that health institutions are not keeping up with clinician demand for AI solutions.

Healthcare challenges:

• Worryingly, 28% of clinicians admit they don't have enough time to deliver quality care, driven by high patient volume. 69% of clinicians report seeing more patients now than 2 years ago, and nearly half (47%) believe tiredness has impaired their ability to treat patients effectively.

AI use increases but many still use generic tools:

• 48% of clinicians say they have used an AI tool for work, nearly double the 26% reported in last year's Clinician of the Future: Attitudes toward AI survey.

• Usage of AI for work purposes was highest amongst respondents from China (71%) and lowest in the US (36%) and UK (34%).

• 97% of AI-using clinicians reported using a generalist tool such as ChatGPT, whereas only 76% have used a specialized AI tool developed for clinical clinical-specific AI tool.

AI enthusiasm is not matched by usage:

• 95% of clinicians reported seeing a benefit in leveraging generative AI for clinical activities in last year’s Clinician of the Future: Attitudes toward AI report, and this year’s survey shows confidence that AI can help save clinicians time and help to improve patient outcomes in the next 2-3 years.

• 41% think in two to three years “clinicians using AI tools will deliver higher quality care than those that don’t”.

• However, today only 16% are using AI tools to actually help make clinical decisions. This is despite an additional 48% of Clinician of the Future 2025 participants expressing a desire to use AI to help with clinical determinations.

Trusted content builds trust in AI

• Clinicians cite several approaches that would increase trust in clinical-specific AI tools, including tools automatically citing references (68%), being trained on high-quality, peer reviewed content (65%), and utilizing the latest resources (64%).

• The desire for AI tools to be trained for factual accuracy is highest in the US (75%) and the UK (81%).

Barriers to AI access:

• Just 32% of those surveyed feel their institution provides adequate access to AI technologies, and only 30% have received sufficient training.

• A substantial need for AI management and oversight has also surfaced with only 29% of respondents indicating their organization provides adequate AI governance.

Jan Herzhoff, President of Elsevier Health, said, “As the healthcare industry continues to grapple with increased demands and limited resources, clinicians have identified many opportunities for AI to provide quality care faster and to help improve patient outcomes. This is a transformative time and we look forward to working alongside the healthcare community to harness the full potential of AI to deliver for patients.”

The Clinician of the Future Report is now in its fourth year – for more information about Clinician of the Future 2025 visit here.

엘스비어 소개

엘스비어는 첨단 정보와 의사결정 지원 분야를 선도하는 글로벌 기업입니다. 100년 넘게 과학과 의료의 발전을 뒷받침하며 인류의 더 나은 미래를 위해 노력해왔습니다. 우리는 전 세계 170개국의 대학 및 기업 연구자, 의사, 간호사, 차세대 보건의료 인력과 교육자들이 중요한 업무를 수행할 수 있도록 지원하고 있습니다. 우리는 신뢰할 수 있는 근거 기반의 과학과 의학 콘텐츠에 첨단 인공지능(AI) 기술을 접목한 핵심 인사이트와 혁신적인 솔루션을 제공함으로써, 이들의 더 나은 성과 달성을 돕고자 합니다. 우리는 제품과 조직 문화 전반에 포용성과 지속 가능성의 가치를 반영하고, 함께하는 커뮤니티와의 협력을 통해 이를 실천해 나가고 있습니다. 엘스비어 재단(Elsevier Foundation)은 세계 곳곳에서 연구 및 보건 분야의 협력 사업을 후원하고 있습니다.

엘스비어는 전문가 및 비즈니스 고객을 위한 정보 기반 분석 및 의사결정 도구를 제공하는 글로벌 기업 RELX의 계열사입니다. 자세한 내용은 www.elsevier.com에서 확인하실 수 있으며, SNS @ElsevierConnect를 통해 최신 소식도 실시간으로 받아보실 수 있습니다.